Skip to main content
Premium Trial:

Request an Annual Quote

AxCell Wins US Patent Covering Synthetic Ligand-Based Proteomic Technology

NEW YORK, Nov. 1 - AxCell Biosciences has been awarded a US patent covering nine claims to the company's Cloning of Ligand Targets proteomics technology, AxCell said on Thursday.

“This technology permits the use of ligands … to discover new domains and ultimately new proteins that may be useful as drug targets,” John Rodwell, president and chief technical officer of AxCell, said in a statement.

The patent, numbered 6,309,820 and entitled “Polypeptides Having a Functional Domain of Interest and Methods of Identifying and Using Same,” deals with a technology that AxCell says can enable researchers to measure protein interactions “in an industrialized, high-throughput manner.”

The nine claims deal cover the methods by which AxCell “identified SH3 domain-containing proteins from human protein expression libraries,” the company said in the statement. According to Princeton, NJ-based AxCell, proteins with these domains “play a role” in cancer, cardiovascular disease, central nervous system disorders, diabetes, and inflammatory disease.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.